The urinary excretion and the antimalarial activity of CI-501 (cycloguanil-pamoate, Camolar) against vivax and falciparum malaria.
D000962:Antimalarials / Q000627:therapeutic use*; D006801:Humans; D007273:Injections, Intramuscular; D008288:Malaria / Q000188:drug therapy*; D010963:Plasmodium falciparum / Q000187:drug effects*; D010966:Plasmodium vivax / Q000187:drug effects*; D014556:Urine
D000962:Antimalarials